Cholesterol Embolization Syndrome Post Invasive Arterial Procedure: A Case Report.
| Autor: | Akpala C; Dermatology, Mayo Clinic Alix School of Medicine, Rochester, USA., Kim G; Dermatology, Mayo Clinic, Rochester, USA., Froehling D; Vascular Surgery, Mayo Clinic, Rochester, USA., Comfere N; Dermatology/Pathology, Mayo Clinic, Rochester, USA., Sominidi Damodaran S; Dermatology/Pathology, Mayo Clinic, Rochester, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Oct 13; Vol. 15 (10), pp. e46986. Date of Electronic Publication: 2023 Oct 13 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.46986 |
| Abstrakt: | Cholesterol embolization syndrome (CES) is a rare but systemic severe disease caused by the distal showering of cholesterol crystals after angiography, major surgery, thrombolysis, or anticoagulation. Here, we present a case of a 74-year-old male with a history of coronary artery disease, chronic kidney disease, peripheral vascular disease, antiphospholipid syndrome, and right internal carotid artery occlusion who developed purple discoloration and ulceration involving several toes two months after coronary artery bypass surgery. A broad differential diagnosis for blue toes was considered, and a biopsy was obtained, which revealed an arterial lumen filled with large cholesterol crystal spaces, confirming the diagnosis of CES. Treatment of CES remains a bimodal approach of supportive and prophylactic care. Although there is no direct evidence in favor of antiplatelet agents, their use seems reasonable because they have been shown to reduce the risk of other cardiovascular events in patients with extensive atherosclerosis. In this case, the patient's toe pain improved with the use of topical amitriptyline ketamine and has achieved complete resolution of pain and skin discoloration at a seven-month follow-up. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Akpala et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|